相关实验视频
Updated: Mar 15, 2026

08:58
Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
17.1K
一个简单的查策略,代谢功能障碍相关的脂肪性肝病在一般健康检查中的简单查策略
Masahito Katahira1,2, Shin-Ichi Shirokami2, Satoko Ono2
1Department of Nursing, School of Nursing and Health, Aichi Prefectural University, Nagoya, Japan.
Metabolic syndrome and related disorders
|March 13, 2026
概括
一个新的评分系统使用人口统计和生物化学数据准确估计脂肪性肝病 (SLD). 这种工具有助于检测代谢功能障碍相关的脂肪性肝病 (MASLD),并补充成像诊断.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 诊断医学 诊断医学
- 生物化学 生物化学
背景情况:
- 非酒精性脂肪性肝病 (NAFLD) 现在是代谢功能障碍相关的脂肪性肝病 (MASLD).
- 需要精确的非侵入性诊断工具来诊断脂肪性肝病 (SLD).
- 目前的指数,如FLI,HSI和NAFLD峰得分有局限性.
研究的目的:
- 开发和验证一个新的评分系统来估计SLD.
- 将新得分的诊断性能与现有指数进行比较.
- 评估分数在识别MASLD时的有用性.
主要方法:
- 对21056个人的数据进行了回顾性分析.
- 使用多变量逻辑回归的评分系统的开发.
- 用于性能评估的接收器操作特征 (ROC) 曲线分析.
主要成果:
- 开发了一个六个变量的得分 (年龄,BMI,HDL,HbA1c,ALT,白蛋白).
- 与FLI,HSI和NAFLD山脊得分相比,新型得分显示出更高的诊断性能 (更高的AUC).
- 与超声波学更强的一致性,特别是对于MASLD标准.
结论:
- 新的评分系统是估计SLD的准确和有用的工具.
- 这一分数可能会提高MASLD检测,当与超声波使用时.
相关概念视频
Ultrasound II: Endoscopic Ultrasound and FibroScan
992
Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Endoscopic Ultrasound (EUS):
992
Overview of Lipid Metabolism
6.4K
Lipid metabolism is a crucial process in the human body that involves the synthesis and degradation of lipids. This process is essential for energy production, cell membrane formation, and hormone production, among other functions.
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
Lipolysis: The Breakdown of Lipids:
Lipolysis is the process of breaking down lipids, particularly triglycerides, into glycerol and fatty acids. This process typically occurs in the adipose tissue and is triggered by various hormones, including glucagon and...
6.4K
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
248
In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess...
248
Serum Laboratory Studies, Stool Test, Breath Test
1.0K
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
1.0K
Overview of Fatty Acid Metabolism
37.6K
Lipids also are sources of energy that power cellular processes. Like carbohydrates, lipids are composed of carbon, hydrogen, and oxygen, but these atoms are arranged differently. Most lipids are nonpolar and hydrophobic. Major types include fats and oils, waxes, phospholipids, and steroids.
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
Fatty acids are catabolized in a process called beta-oxidation, which takes place in the matrix of the mitochondria and converts their fatty acid chains into two-carbon units of acetyl groups. The acetyl...
37.6K
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
310
Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug...
310

